Loading
India's official cancer count: about 1.39 million new cancers in 2020, led by breast, lung, mouth, cervix and tongue, with most breast, cervical and head and neck cancers found only once locally advanced.
Analysis of 28 population-based and 58 hospital-based registries of the ICMR National Cancer Registry Programme (667,666 cases, 2012-2016). The projected number of cancer patients in India for 2020 was 1,392,179. The five leading sites were breast, lung, mouth, cervix uteri and tongue. Most patients presented at a locally advanced stage (breast 57.0%, cervix 60.0%, head and neck 66.6%, stomach 50.8%), while lung cancer presented mainly with distant metastasis (44.0% of men, 47.6% of women). Incidence rose over time at all registries, fastest in Kamrup urban (3.8% annual change); the highest age-adjusted rates were in Aizawl (men, 269.4 per 100,000) and Papumpare (women, 219.8). A 2022 update estimated 1,461,427 cases and a 12.8% rise by 2025.
India's cancer problem is a late-diagnosis problem as much as a treatment problem: the same cancers that dominate (oral, cervical, breast) are the ones screening and vaccination can prevent or catch early. The numbers set the priorities of the National Cancer Grid, PM-JAY oncology packages and the national screening programme.
Shares National Cancer Registry Programme (ICMR-NINE, Bengaluru), Cancer registries and population surveillance, Cervical cancer, Head and neck squamous cell carcinoma.
Shares National Cancer Registry Programme (ICMR-NINE, Bengaluru), Cancer registries and population surveillance, Cervical cancer, Head and neck squamous cell carcinoma.
Shares Cancer registries and population surveillance, Cervical cancer, Gastric & gastro-oesophageal junction cancer, Head and neck squamous cell carcinoma.
Shares Indian Council of Medical Research, The hardest cancers are found late, Cervical cancer, Head and neck squamous cell carcinoma.
Shares Cancer registries and population surveillance, Cervical cancer, Gastric & gastro-oesophageal junction cancer, HR-positive / HER2-negative breast cancer.
Shares Cancer registries and population surveillance, Cervical cancer, Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
Shares Cancer registries and population surveillance, Cervical cancer, Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer.
Shares Cancer registries and population surveillance, Cervical cancer, Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer.